People | November 22, 2024
Strides Pharma Science appoints Dr. C. Muthulingam as Executive VP - R&D
Dr. Muthu was last associated with Mankind Pharma
Dr. Muthu was last associated with Mankind Pharma
The brand has launched 6 new range of products to provide a complete pregnancy care solution
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
A primary investment of Rs 194.4 crore has been made
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
Subscribe To Our Newsletter & Stay Updated
